Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Thirty years ago, the merger of Ciba-Geigy and Sandoz brought together two of Switzerland’s most storied companies and…
Novartis marks 30 years of breakthroughs, building on 250 years of discovery to reimagine what medicine can do next
Thirty years ago today, the merger of Ciba-Geigy and Sandoz brought together two of Switzerland’s most storied companies…
Novartis (SWX:NOVN) Wins Full FDA Nod For Fabhalta And Wider EU Itvisma Use
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Novartis…
The Future of Autoimmune Disease: A Q&A You Need to Read
We sat down with Christy Siegel, SVP and Therapeutic Area Head, Immunology, Novartis US, to explore how the…
Roche Ends Both Huntington’s Disease Drug Programs After Biomarkers Beat Patients
In a letter sent to global Huntington’s disease patient community leaders on July 9, 2026, Swiss pharmaceutical giant…
Roche culls development of two Huntington’s disease programmes
Roche has stopped development of two of its Huntington’s disease candidates after one failed to show benefit in…
A Conversation Women Wish They’d Had: Understanding the Risk of Breast Cancer Coming Back
For many women, the end of breast cancer treatment is described as a turning point, bringing mixed emotions…
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Novartis Pharma AG First gene replacement therapy in the EU for broad population with SMA, including children two…
Novartis (SWX:NOVN) Wins EU Approval For Itvisma In A Broader SMA Market
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
Novartis Pharma AG First gene replacement therapy in the EU for broad population with SMA, including children two…
The Novartis Next Generation Cancer Care Survey: A New Conversation about Care
People living with cancer today are navigating two realities at once: a moment of extraordinary scientific progress, and…
Novartis in Albania | Novartis Albania
Novartis in Albania aims to discover and advance medical breakthroughs to improve the quality of life and longevity…